A novel combination for in vivo breast cancer treatment: TAK1 inhibition combined with metformin and Lentinula edodes compounds synergistically reinvigorates CD8+ T Cells.
Saved in:
| Title: | A novel combination for in vivo breast cancer treatment: TAK1 inhibition combined with metformin and Lentinula edodes compounds synergistically reinvigorates CD8+ T Cells. |
|---|---|
| Authors: | Mahdavi AS; Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran., Bagheri N; Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran., Marincola FM; Translational and Advanced Medicine (TAM) Biosciences, Nashville, TN, USA., Khosravian P; Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran., Ghatrehsamani M; Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, PO Box: 88155-571, Shahrekord, Iran. mahdi.samani.2020@gmail.com. |
| Source: | Journal of translational medicine [J Transl Med] 2026 May 05; Vol. 24 (1). Date of Electronic Publication: 2026 May 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42087141 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A novel combination for in vivo breast cancer treatment: TAK1 inhibition combined with metformin and Lentinula edodes compounds synergistically reinvigorates CD8<superscript>+</superscript> T Cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mahdavi+AS%22">Mahdavi AS</searchLink>; Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.<br /><searchLink fieldCode="AU" term="%22Bagheri+N%22">Bagheri N</searchLink>; Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.<br /><searchLink fieldCode="AU" term="%22Marincola+FM%22">Marincola FM</searchLink>; Translational and Advanced Medicine (TAM) Biosciences, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Khosravian+P%22">Khosravian P</searchLink>; Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.<br /><searchLink fieldCode="AU" term="%22Ghatrehsamani+M%22">Ghatrehsamani M</searchLink>; Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, PO Box: 88155-571, Shahrekord, Iran. mahdi.samani.2020@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101190741%22">Journal of translational medicine</searchLink> [J Transl Med] 2026 May 05; Vol. 24 (1). <i>Date of Electronic Publication: </i>2026 May 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101190741 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1479-5876 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214795876%22">14795876 </searchLink><i>NLM ISO Abbreviation: </i>J Transl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42087141 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12967-026-07905-9 Languages: – Code: eng Text: English Titles: – TitleFull: A novel combination for in vivo breast cancer treatment: TAK1 inhibition combined with metformin and Lentinula edodes compounds synergistically reinvigorates CD8+ T Cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mahdavi AS – PersonEntity: Name: NameFull: Bagheri N – PersonEntity: Name: NameFull: Marincola FM – PersonEntity: Name: NameFull: Khosravian P – PersonEntity: Name: NameFull: Ghatrehsamani M IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 05 Text: 2026 May 05 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1479-5876 Numbering: – Type: volume Value: 24 – Type: issue Value: 1 Titles: – TitleFull: Journal of translational medicine Type: main |
| ResultId | 1 |
